企業プロフィール
CytoSorbents 株価・ニュース・カタリスト
- ティッカー:
- CTSO
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価パフォーマンス
0.31 USD (-12.61%)
終値
最終更新: 2026年8月20日
30.1M USD
時価総額
株価変動の要因
As of Aug 20, 2026, CTSO closed down 12.6% at $0.3111. No new same-company headline was identified in the current news window.
企業概要
事業概要
CytoSorbents is a medical technology company focused on blood purification and extracorporeal filtration systems. Its business is centered on critical-care and device-based purification rather than biotech development.
所在地とセクター分類
Headquartered in the United States and listed on NASDAQ, CytoSorbents sits in medical devices and critical-care technology.
ビジネスモデルの特徴
The company depends on clinical adoption, hospital procurement, and the expansion of its blood-purification platform.
バイオ業界での位置付け
CytoSorbents is a niche medtech name whose valuation is tied to adoption and clinical utility.
今後のカタリスト
- CytoSorbents’ catalysts are CytoSorb adoption, international reimbursement, and any update that shows hospital usage is stabilizing. The company needs to keep proving that the therapy can become a recurring part of critical-care workflow.
最近のニュース
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。